Mübeccel Akdis

Prof Mübeccel Akdis MD, PhD Head of Immune Regulation Swiss Institute of Allergy and    Asthma Research (SIAF)

 

Dr Akdis is working in the Swiss Institute of Allergy and Asthma Research (SIAF) since 1995 and received her PhD in Immunology. She worked as a postdoctoral scientist and became a group leader at SIAF, where she has established her own research group in 2003. Dr Akdis made her habilitation in Zurich University Medical Faculty on Experimental Immunology in 2005 and became a professor in 2015. She has published 267 Peer-reviewed articles, Sum of times cited : 31`800 and her h-index: 83 (92-scopus). She has received research grants and collaborative grants from the Swiss National Foundation, European Union (MeDALL and Predicta) and Sean Parker Seed Grant. She received numerous awards, including International Distinguished Fellow Award of the American College of Allergy, Asthma & Immunology (ACAAI), 2018. EAACI, Paul Ehrlich Award 2020 for Experimental Research. Anerkennungspreis der Regierung des Kantons Graubünden, Kantons Graubunden recognition preis 2020. 2021 Bulent Eczacibasi Medical Science Award.

Kapat

Cezmi Akdis

Kısa Biyografi: 1961 de Bursa’da doğan Cezmi Akdiş, ilkokulu Bursa Atatürk İlkokulu’nda orta ve lise eğitimini Bursa Anadolu Lisesi’nde tamamlamıştır. 1985 yılında Uludağ Üniversitesi Tıp Fakültesinden mezun olup, Burdur, Gölhisar’da 2 yıl mecburi hizmet yaptıktan sonra, 1987-1991 yıllları arasında Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji ihtisasını, 1991-1994 yılları arasında İmmünoloji yandal ihtisasını Uludağ Üniversitesi Tıp Fakültesi’nde yapmıştır. 1993 yılında yardımcı  doçent, 1996 yılında doçent olmuştur. 1993 yılında Ciba-Geigy Basel’de, 1994 yılında İsviçre Allerji ve Astım Araştırma Merkezi’nde Davos’ta çalışmaya başlamıştır. 1998 yılında İsviçre Allerji ve Astım Araştırma Merkezi’nde (SIAF) immunoloji grup başkanı olmuştur.
2002 yılında Zürih Üniversitesi Tıp Fakültesinde “Venia Legendi” ünvanı almış,
2006 İsviçre Allerji ve Astım Araştırma Merkezi’ne direktör ve Zurih Universitesinde extraordinaryüs profesör olmustur.
2008 yılında Türkiye Ulusal Bilim Akademisi (TUBA) asil üyesi olmustur.

Cezmi Akdiş Avrupa Allerji ve Klinik İmmunoloji Akademisi’nde (EAACI), 13 yıl yonetim kurulu üyeligi ve 2011-2013 yılları arasında baskanlık görevlerinde bulunmuştur.  
Onbeş kez yapilan World Immune Regulation toplantılarının düzenleyicisidir.
Cezmi Akdiş 2015-2018 arası Journal of Allergy Clinical Immunology’nin bas editorlügünü yapmıstır
2018 den beri Avrupanın en ust duzey Allerji ve Klinik Immunoloji Dergisi olan Allergy’nin (IF 13.15) bas editorudur.
Cezmi Akdiş aralarında Ferdinand Wortman, Pharmacia, Hoechst Marion Roussel, Professor Hans Storck, Dr.-Karl Heyer, Sedat Simavi, Allergopharma, Foundation of Allergy Research Europe (FARE) altın madalyası, Tubitak Bilim özel ödülü, Dünya Allerji Organizasyonu özel ödülü  Amerikan Allerji Astim Immunoloji Akademisi Elliot Middleton Odülü, Harold Nelson Onursal Odülü, Robert Goltz Onursal Dersi (Minneapolis Univ), Cantonal Recognition Prize, Erich Fuchs Award Alman Allerji Immunoloji Dernegi Odülü, Asia Pacific Allerji Society (APAACI) Lifetime Recognition Award de bulunan bir çok uluslarası ödüle layık görülmüştür.

1994 yilindan beri yaptigi arastirmalarla, 2 Milyar’dan fazla hasta ve hastaligi aciklayan “Epitel Bariyer Hipotezi’nin gelistiricisidir”

Cezmi Akdis Zürih Universitesi Tip Fakültesinde Ordinarius Profesordür. 
2014 yilindan beri Isvicre Bilim Akademisinin Senato Uyesidir.
700 kadar yayini vardir. H-indexi Web of Science da 109,  Google Scholar da 129 dür. 68’000 adet sitasyon almistir.
Pekin Kantonal Universitesi ve Wuhan Universitesinde onursal profesördür.

Kapat

Thomas R. Gildea, MD, MS, FCCP, is the Section Head of Bronchoscopy in the Department of Pulmonary, Allergy and Critical Care Medicine and Transplant Center in the Respiratory Institute at the Cleveland Clinic. He is internationally recognized as a thought leader in advanced diagnostic and therapeutic bronchoscopy approaches and techniques. He is an innovator and inventor of groundbreaking airway disease innovations. An invited lecturer at national and international medical meetings and a member of several industry scientific advisory boards, Dr. Gildea is expert in the field on interventional pulmonary medicine.

Kapat

CV MICHELE VITACCA MD

Full name: MICHELE VITACCA Date of birth: 26/01/1961              Gender: MALE

Current post: Director of Respiratory Department network ICS Maugeri IRCCS Pavia (Italy), Director of Respiratory Rehabilitative Unit ICS Maugeri IRCCS Lumezzane (Bs) Italy Previous posts: 1. Institute Director of Rehabilitative center Fondazione Salvatore Maugeri IRCCS Via Mazzini 129, Lumezzane (BS) (1° may 2014-28 feb 2015) 2. Scientific Director of Rehabilitative center Fondazione Salvatore Maugeri IRCCS Via Mazzini 129, Lumezzane (BS) ( 1° jul 2010-1° sept 2014) 3. Medical doctor of Rehabilitative Respiratory Unit and weaning center Fondazione Salvatore Maugeri IRCCS Via Mazzini 129, Lumezzane (BS) (Jan 1989-1 march 2006) 4. Medical doctor in Helicopter Emergency Service Ospedale Civile Brescia (jul 1987-dic 1988) Initial university/medical school: 1. Graduated in Medicine (1987) University of Brescia 2. Mastered in Anaestesia and Intensive Care (1990) University of Parma  3. Mastered in Respiratory Diseases (1994) University of Pavia 4. Mastered in Health managing  University of Insubria (VA)

Postal address: 25066 Via Mazzini 129, Lumezzane (BS) Italy; Telephone number: 0039 339 1501050  0039 30 8253182;  Email: [email protected]

National/international roles

National societies: AIPO (Associazione Italiana Pneumologi Ospedalieri) Chief of subgroup rehabilitation and home care 2016-2017 and AIPO (Associazione Italiana Pneumologi Ospedalieri) Vicepresident Lombardy AIPO group 2018-2019 . Guideline panels: 1. Expert member invited in the “ERS ATS Internation Consensus Conferences in intensive Care Medicine: Non invasive positive pressure ventilation in acute respiratory failure” 2001 2. Chief of AIPO Task Force on “Monitoring and care of neuromuscular and motoneuron diseases in respiratory setting” 2010 3. Active member of Task force Pulmonologist and Neurologist on “Diagnosis and Management of Glycogenosis II” 2011 4. ERS Task Force chair of “Telemonitoring of ventilator-dependent patients” (TF-2013-10).

Citation

I am involved as clinician and researcher in the respiratory filed since 1989. My professional history started as Intensivist located inside a rehabilitative respiratory unit dedicated to chronicity. After academic specialization in Respiratory Diseases I have structured a weaning center dedicated to chronic cardio-respiratory patients coming from ICUs. I have the focused my attention on chronicity in the field of non invasive mechanical ventilation, mechanics, weaning modalities, weaning units, rehabilitation in weaning units, respiratory rehabilitation, long term care, neuromuscular diseases with specific interests in ALS. More recently my attention is focused on continuity of care systems as telemonitoring, home care and caregivers’ attention. Last but not least palliative care and end of life approach for non oncological diseases are two important clinical and research field of interest.     In the last years I has been involved in differrent Scientific Societies (European Respiratory Society, European Lung Foundation, Associazione Italiana Pneumologi Ospedalieri, AISLA) in different local and Ministerial Italian committee dedicated to home mechanical ventilation and home care, to respiratory rehabilitation , in patient association (ALS patient association named AISLA). I have been involved in an European task force accepted by ERS on telemonitoring for respiratory diseases. I have conducted hundred reviewer activities for European Respiratory Journal, Intensive Care Medicine, Chest, Respiration, Respiratory Medicine, Respiratory Care, Lancet, Thorax, COPD, Pulmonology, Monaldi Archives for Chest diseases, Rassegna di Patologia dell’Apparato Respiratorio, Medical Journal of Person. I have been invited in hundred of Italian seminars and meetings and more then 190 international congresses and meeting as speaker. I have partecipated as invited professor in 4 Italian Universities (Brescia, Milano, Trieste, Modena)

Research contribution

I have producted more than 30 chapters for national and international books, 24 original papers not cited in Pubmed and 227 original indexed papers cited in Pubmed Citation H index (SCIVAL-Italian Minister of Health) = 38 H index (Web of science) = 34; times cited = 4215; average citation item = 20.1

Contributions to education and clinical practice

Education: Academic  invitation at University of Brescia Degree in Physiotherapy, University of Milano Master of Respiratory Rehabilitation, University Cattolica of Milano Master of caregivers, University of Modena Master of chronic patients, University of Brescia Master of Intensivists, University of Trieste Master of Respiratory Therapist.

Main publications

Vitacca, Foglio, Scalvini, Marangoni, Quadri, Ambrosino. "Time course of pulmonary function before admission into an ICU A two year retrospective study of COLD patients with hypercapnia" Chest 1992;102;1737-41. Vitacca, Rubini, Foglio, Scalvini, Nava , Ambrosino "Non invasive modalities of positive pressure ventilation improve the outcome of acute exacerbations in COLD patients" Intensive Care Med 1993 19:450-455 Vitacca, Clini, Foglio, Scalvini, Marangoni, Quadri, Ambrosino  “Hygroscopic condenser humidifiers in chronically tracheostomized patients who breathe spontaneously" Eur Respir J 1994 ,7,2026-2032 Vitacca, Clini, Rubini, Nava, Foglio, Ambrosino.”Non invasive mechanical ventilation in severe chronic obstructive lung disease and acute respiratory failure:short and long term prognosis” Intensive Care Medicine 1996  22:94 -100 Vitacca, Clini, Porta, Ambrosino. ”Acute exacerbations in patients with COPD :predictors for need of mechanical ventilation” Eur Respir J 1996;9,1487-1493. Vitacca M, Clini E, Facchetti D, Pagani M, Poloni M, Porta R Ambrosino N. Breathing pattern and Respiratory mechanics in patients with amyotrophic lateral sclerosis. Eur Respir J 1997; 10:1614-1621. Vitacca M, Natalini G, Cavaliere S, Clini E, Foccoli P, Candiani A, Ambrosino N. Breathing Pattern and arterial gases during Nd-Yag laser photoresection of endobronchial lesions under general anesthesia: use of negative pressure ventilation. Preliminary study. CHEST 1997;112:1466-73 Vitacca M, Bianchi L, Clini E, Ambrosino N. “Acute effects of deep diaphragmatic breathing in COPD recovering from an acute episode of exacerbation” Eur Respir J 1998;11:408-415 Nava S, Ambrosino N, Clini E, Prato M, Orlando G, Vitacca M, Brigada P, C Fracchia, Rubini F. “ Non invasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized controlled trial. Ann Intern Med 1998;128:721-728. M Vitacca et al.” Breathing Pattern and respiratory mechanics in patients with ALS”. Selected abstract from Eur Respir J CHEST 1998 vol. 114 N°1 A-16 M. Vitacca, R. Porta , L. Bianchi, E. Clini, N. Ambrosino. Differences in spontaneous breathing pattern and mechanics in patients with severe COPD recovering from acute exacerbation. Eur Respir J 1999; 13:365-370 Vitacca M, Clini E, Pagani M, Bianchi L, Rossi A, Ambrosino N. Physiologic effects of early administered mask proportional assist ventilation in patients with chronic obstructive pulmonary disease and acute respiratory failure. Crit Care Med 2000 Jun; 28 (6):1791-7 M. Vitacca, E Clini, R. Porta, N. Ambrosino. “Preliminary results on nursing workload in a dedicated weaning center”. Intensive Care Med 2000:26:796-799 M. Vitacca, Stefano Nava, Marco confalonieri, Luca Bianchi,  Roberto Porta, Enrico Clini, Nicolino Ambrosino. The appropriate setting on noninvasive pressure support ventilation in stable COPD patients.  CHEST 2000; 118:1286-1293 Vitacca M, Vianello A, Colombo D, Clini E, Porta R, Bianchi L, Arcaro G, Guffanti E, Lo Coco A, Ambrosino N. “Comparison of two methods for weaning COPD patients requiring mechanical ventilation for more than 15 days”. Am J Respir Crit Care Med 2001; 164: 225-230. M. Vitacca, N. Ambrosino, E. Clini, R. Porta, C. Rampulla, B. Lanini and S. Nava. “Physiological response to pressure support ventilation delivered before and after extubation in COPD patients not capable of totally spontaneous autonomous breathing”. Am J Respir Crit Care Med 2001; 164:638-641. M.Vitacca, L.Barbano, S. D’Anna, R. Porta, L. Bianchi and N. Ambrosino. “Comparison of five bilevel pressure support ventilators in patients with chronic ventilatiry failure. A physiologic  study”. CHEST 2002;122:2105-2114 M. Vitacca, L. Bianchi,  E. Zanotti ,  A. Vianello, M. Zigliani, L. Barbano, R. Porta, E. Clini. Assessment of physiological variables and subjective comfort under different levels of pressure support ventilation. CHEST 2004; 126:851-859 Michele Vitacca, Giovanna Callegari, Maria Sarvà, Luca Bianchi, Luca Barbano, Bruno Balbi, Nicolino Ambrosino. Physiological effects of meal in difficult-to wean tracheotomised patients with chronic obstructive pulmonary disease. Intensive Care Medicine 2005; 31:236-242. Michele Vitacca, Luca Bianchi, Luca Barbano, Mara Ziliani, Nicolino Ambrosino. Effects of acute on  chronic respiratory failure on Hypercapnia and three-month survival. CHEST 2005;128:1209–1215 M. Vitacca, M. Paneroni, L. Bianchi, E. Clini, A. Vianello,  P. Ceriana ,  L. Barbano, B. Balbi, S. Nava. Maximal inspiratory and expiratory pressure measurement in tracheotomised patients. ERJ 2006; 27:343-349  Michele Vitacca, MD, Luca Bianchi, MD, Maria Sarvà MD, Mara Paneroni RT, Bruno Balbi MD. “Physiological responses to arm exercise in difficult to wean patients with COPD” ICM 2006 32:1159-1166 M. Vitacca, L. Bianchi, A. Guerra, C. Fracchia, A.Spanevello, B. Balbi, S.Scalvini.   Tele-assistance in Chronic Respiratory Failure Patients: a Randomised Clinical Trial. Eur Respir J   2009; 33: 411–418 M. Vitacca, M. Grassi, L. Barbano, G. Galavotti, C. Sturani, A. Vianello, E. Zanotti, L. Ballerin, A. Potena, R. Scala, A. Peratoner, P. Ceriana, L. Di Buono, E. Clini, N. Ambrosino, N. Hill, S. Nava. Last 3 months of life in home ventilated patients: the family perception. Eur Respir J   2010  35:1-8 Michele Vitacca, Mara Paneroni, Debora Trainini, Luca Bianchi, Giuliano Assoni, Manuela Saleri, Sonia Gilè, João C. Winck, Miguel R. Gonçalves. A Home Based On Demand Mechanical Cough Assistance Program for Patients with Amyotrophic Lateral Sclerosis. American Journal of  Physical Medicine & Rehabilitation 2010  vol  89; 5: 401-406 Vitacca M, Vianello A; Scientific Group on Respiratory Intensive Care of the Italian Association of Hospital Pulmonologists Respiratory outcomes of patients with amyotrophic lateral sclerosis: an Italian nationwide survey. Respir Care. 2013 Sep;58(9):1433-41. doi: 10.4187/respcare.02236. Epub 2013 Feb 19. Vitacca M, Scalvini S, Volterrani M, Clini EM, Paneroni M, Giordano A, Ambrosino N. In COPD patients on prolonged mechanical ventilation heart rate variability during the T-piece trial is better after pressure support plus PEEP: a pilot physiological study. Heart Lung. 2014 Sep-Oct;43(5):420-6. doi: 10.1016/j.hrtlng.2014.04.003. Epub 2014 May 22. Vitacca M. Telemonitoring in patients with chronic respiratory insufficiency: expectations deluded? Thorax. 2016 Apr;71(4):299-301. No abstract available. Michele Vitacca FERS, Dicle Kaymaz, Barbara Lanini, Guido Vagheggini, Pınar Ergün, Francesco Gigliotti, Nicolino Ambrosino FERS, Mara Paneroni . NON-INVASIVE VENTILATION DURING CYCLE EXERCISE TRAINING IN PATIENTS WITH CHRONIC RESPIRATORY FAILURE ON LONG TERM VENTILATORY SUPPORT: A RANDOMISED CONTROLLED TRIAL. Respirology 2017 doi: 10.1111/resp.13181 Vitacca, Michele; Montini, Alessandra; Lunetta, Christian; Banfi, Paolo; Bertella, Enrica; De Mattia, Elisa; Lizio, Andrea; Volpato, Eleonora; Lax, Agata; Morini, Roberta; Paneroni, Mara. Impact of an early respiratory care program with NIV adaptation in patients with ALS . Eur J Neurol. 2018 Mar;25(3):556-e33. doi: 10.1111/ene.13547. Epub 2018 Jan 29. Michele Vitacca; Irene Pietta, PT; Marta Lazzeri, PT; Mara Paneroni, MSc Associazione Italiana Riabilitatori Insufficienza Respiratoria (ARIR) and Associazione Italiana Pneumologi Ospedalieri (AIPO) rehabilitation group. EFFECT OF HIGH-FLOW NASAL THERAPY DURING EXERCISE TRAINING IN COPD PATIENTS WITH CHRONIC RESPIRATORY FAILURE: STUDY PROTOCOL FOR A RANDOMIZED CONTROLLED TRIAL. Trials. 2019 Jun 8;20(1):336. doi: 10.1186/s13063-019-3440-2. Vitacca M, Paneroni M, Braghiroli A, Balbi B, Aliani M, Guido P, Fanfulla F, Pertosa M, Ceriana P, Zampogna E, Raccanelli R, Sarno N, Spanevello A, Maniscalco M, Malovini A, Ambrosino N  Exercise Capacity and Comorbidities in Patients With Obstructive Sleep Apnea. J Clin Sleep Med. 2020 Apr 15;16(4):531-538. doi: 10.5664/jcsm.8258. Michele Vitacca 1a, Mara Paneroni 1a, Elisabetta Zampogna 1b, Dina Visca 1b,  Annalisa Carlucci 1c, Serena Cirio 1c, Paolo Banfi 2a, Gabriele Pappacoda 2a, Ludovico Trianni 3, Antonio Brogneri 3, Stefano Belli 1d, Elena Paracchini 1d, Maria Aliani 1e, Vito Spinelli 1e, Francesco Gigliotti 2b, Barbara Lanini 2b, Marta Lazzeri 4, Enrico M Clini 5, Alberto Malovini6, and Nicolino Ambrosino 1f,  on behalf of Associazione Italiana Riabilitatori Insufficienza Respiratoria (ARIR) and Associazione Italiana Pneumologi Ospedalieri (AIPO) rehabilitation group. HIGH-FLOW OXYGEN THERAPY DURING EXERCISE TRAINING IN PATIENTS WITH COPD AND CHRONIC HYPOXEMIA: A MULTICENTER RANDOMIZED CONTROLLED TRIAL. Phys Ther. 2020 Apr 24. pii: pzaa076. doi: 10.1093/ptj/pzaa076 Vitacca, Michele; Nava, Stefano; Santus, Pierachille; Harari, Sergio Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches. Vitacca M, Nava S, Santus P, Harari S. Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches. Eur Respir J. 2020 May 21;55(5). pii: 2000632. doi: 10.1183/13993003.00632-2020 Michele Vitacca, Carone M, Clini EM, Paneroni M, Lazzeri M, Lanza A, Privitera E, Pasqua F, Gigliotti F, Castellana G, Banfi P, Guffanti E, Santus P, Ambrosino N; ITS - AIPO, the ARIR and the SIP/IRS.) Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: the Italian position paper. Respiration. 2020;99(6):493-499. doi: 10.1159/000508399. Epub 2020 May 19. Vitacca M, Malovini A, Balbi B, Aliani M, Cirio S, Spanevello A, Fracchia C, Maniscalco M, Corica G, Ambrosino N, Paneroni M. Minimal Clinically Important Difference in Barthel Index Dyspnea in Patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020 Oct 21;15:2591-2599. doi: 10.2147/COPD.S266243. eCollection Michele Vitacca, Piero Ceriana, Irene Prediletto, Annalisa Carlucci, Mara Paneroni, Nicolino Ambrosino, Stefano Nava. INTRINSIC DYNAMIC POSITIVE END-EXPIRATORY PRESSURE IN STABLE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Respiration. 2020;99(12):1129-1135. doi: 10.1159/000511266. Epub 2020 Dec 3.PMID: 33271563   Paneroni M, Simonelli C, Saleri M, Bertacchini L, Venturelli M, Troosters T, Ambrosino N, Vitacca M. Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia. Am J Phys Med Rehabil. 2021 Feb 1;100(2):105-109. doi: 10.1097/PHM.0000000000001641.PMID: 33181531 Mara Paneroni, Ioannis Vogiatzis,Laura Bertacchini, Carla Simonelli, Michele Vitacca. PREDICTORS OF LOW PHYSICAL FUNCTION IN PATIENTS WITH COVID-19 WITH ACUTE RESPIRATORY FAILURE ADMITTED TO A SUB-ACUTE UNIT. Arch Phys Med Rehabil. 2021 Jan 30:S0003-9993(21)00090-3. doi: 10.1016/j.apmr.2020.12.021. Online ahead of print.PMID: 33529611 Piero Ceriana a, Michele Vitacca * b, Mara Paneroni b, Stefano Belli c, Nicolino Ambrosino d . USEFULNESS OF STEP DOWN UNITS TO MANAGE SURVIVORS OF CRITICAL COVID-19 PATIENTS" Eur J Intern Med. 2021 Mar 6:S0953-6205(21)00065-0. doi: 10.1016/j.ejim.2021.03.002. Online ahead of print.PMID: 33741207  Elisabetta Zampogna, Mara Paneroni, Stefano Belli, Maria Aliani, Alessandra Gandolfo, Dina Visca,Maria Teresa Bellanti, Nicolino Ambrosino, Michele Vitacca. Pulmonary rehabilitation in patients recovering from COVID-19. Respiration. 2021;100(5):416-422. doi: 10.1159/000514387. Epub 2021 Mar 30.PMID: 33784696  Rao F, Garuti G, Vitacca M, Banfi P, Racca F, Cutrera R, Pavone M, Pedemonte M, Schisano M, Pedroni S, Casiraghi J, Vianello A, Sansone VA; UILDM Respiratory group. Management of respiratory complications and rehabilitation in individuals with muscular dystrophies: 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Milan, January 25-26, 2019). Acta Myol. 2021 Mar 31;40(1):8-42. doi: 10.36185/2532-1900-045. eCollection 2021 Mar.PMID: 33870094    Michele Vitacca MD FERS 1, Nicolino Ambrosino MD FERS 2, Stefano Belli MSc 3, Matteo Vigna MD 4, Elisabetta Zampogna MSc 5, Maria Aliani MD 6, Giancarlo Piaggi PT 2, Mara Paneroni MSc1  THE SEVERITY OF ACUTE EXACERBATIONS OF COPD AND THE EFFECTIVENESS OF PULMONARY REHABILITATION. Respir Med. 2021 May 14;184:106465. doi: 10.1016/j.rmed.2021.106465. Online ahead of print.PMID: 34023740 Giuseppe Brunetti,   Michele Vitacca. PULMONARY REHABILITATION IN PATIENTS WITH INTERSTITIAL LUNG DISEASES: CORRELATES OF SUCCESS. Respir Med. 2021 May 19;185:106473. doi: 10.1016/j.rmed.2021.106473. Online ahead of print.PMID: 34038844 Michele Vitacca MD, Mara Paneroni MSc PT, Giuseppe Brunetti MD, Annalisa Carlucci MD, Bruno Balbi MD PhD, Antonio Spanevello MD, Nicolino Ambrosino MD.  PHYSIOLOGICAL AND SYMPTOM CHARACTERISTICS OF SURVIVORS OF COVID-19 ASSOCIATED PNEUMONIA, WITH RESTING NORMOXEMIA AND EXERCISE-INDUCED DESATURATION. Respiratory Care 2021 in press

Kapat

I am a Pulmonologist with a clinical and research expertise in interstitial lung disorders at the Centro Hospitalar e Universitário de Coimbra (CHUC), in Portugal. My PhD studies were based on the effects of caffeine and adenosine receptors on inflammatory respiratory diseases. I am the Director of the research and development department of CHUC, an associate editor of Pulmonology and Respiratory Research and an elected member of the Portuguese National Board of Pulmonology. I currently serve as vice-president of Sociedade Portuguesa de Pneumologia. I was the immediate previous Early Career Member Representative for the European Respiratory Society Assembly 12 - Interstitial Lung Diseases.

Kapat

Dr. Sokolowska is a Head of the Immune Metabolism Department at the Swiss Institute of Allergy and Asthma Research, University of Zurich, Switzerland and the Principal Investigator at the Swiss Federal Institute of Technology in Zürich (ETH)/UZH PhD programme. She is an internationally trained immunologist, bench and data scientist, and an internal medicine clinical specialist with an expertise in innate and adaptive immunity, lipid biology, microbiome, and multi-omics technologies. Her research encompasses involvement of immunometabolism, microbiome and respiratory viruses in immune tolerance and in the pathogenesis of allergic, pulmonary and autoimmune diseases. She authored and co-authored 75 scientific publications in distinguished international journals, including Immunity, Nature Communications, Journal of Allergy and Clinical Immunology,  Journal of Immunology, Journal of Biological Chemistry, Allergy and others. She also contributed to several textbooks in allergy, immunology and molecular biology. She is an active Board Member of the European Academy of Allergy and Clinical Immunology (EAACI), where she co-leads the Immunology Section and several task forces in EAACI, including special COVID-19 initiatives, resulting in the international guidelines and position papers. She is an Editorial Board member in Allergy, Clinical and Molecular Allergy and a member of the Reviewers Board in Frontiers in Pharmacology and Frontiers in Allergy.

Kapat

IOANA OCTAVIA AGACHE

Faculty of Medicine, Transylvania University Brasov

Ioana Agache is Professor of Allergy and Clinical Immunology at Transylvania University, Brasov, Romania and Past President of the European Academy of Allergy and Clinical Immunology (EAACI) 2017-2019. Her research in the field of Asthma and Allergy and Clinical Immunology focused on asthma phenotypes and endotypes, immune modulation and immune tolerance and integrated management of allergic diseases, with a special focus on primary care and community pharmacists. Ioana Agache is member of the Steering Committee and co-author of several international and European Guidelines, such as ARIA (Allergic Rhinits and its impact on Asthma), EAACI Allergen Immunotherapy Guidelines and EAACI Food Allergy and Anaphylaxis Guidelines. Ioana Agache is actually Chair of the EAACI Guidelines on the use of Biologics in asthma and allergic diseases and of the EAACI Guidelines on Environmental Science in Allergy and Asthma. She is Editor of the Global Atlas of Asthma (2013 and 2020), Global Atlas of Allergy (2014), Global Atlas of Allergic Rhinitis and Chronic Rhinosinusitis (2015), Implementing Precision Medicine in Best Practices of Chronic Airway Diseases (2018), Associate Editor of Allergy and Clinical and Translational Allergy and a member of the Editorial Board of Journal of Allergy and Clinical Immunology. Ioana Agache graduated

Kapat

Carlos Robalo Cordeiro, MD, PhD, FERS
Carlos Robalo Cordeiro is the Head of Pulmonology Department at the Coimbra University Hospital and Dean of Coimbra Medical School where he is Full Professor of Pulmonology.
He was President of the Portuguese Society of Pulmonology (2010/ 2015), Executive Committee member of the WASOG – World Association of Sarcoidosis and Other Granulomatosis (2011/2015) and Secretary General of the ERS - European Respiratory Society (2016/2019). 
He was elected in August 2020 for the ERS presidential cycle (Vice President 2020/2021, President Elect 2021/2022, President 2022/2023 and Past President 2023/2024).
His main field of interest is Interstitial Lung Disease, having published 130 papers in impact factor journals and being peer reviewer of 16 national and international journals and Board member of 8 national and international journals.

Kapat

Alan D. L. SIHOE 司 徒 達 麟 醫 生
MBBChir, FRCSEd(CTh), FCSHK, FHKAM

Medical Qualifications:
Bachelor of Medicine and Bachelor of Surgery – University of Cambridge, UK
Fellow, Royal College of Surgeons of Edinburgh
Fellow, College of Surgeons of Hong Kong
Fellow, Hong Kong Academy of Medicine

Other certificates received (for academic reference only):
Bachelor of Arts with Honours – University of Cambridge, UK
Master of Arts – University of Cambridge, UK
Fellow, American College of Chest Physicians (FCCP)
Fellow, American College of Surgeons (FACS)

Selected Academic Positions:
Associate Editor, European Journal of Cardio-Thoracic Surgery
Section Editor, Asian Cardio-Vascular and Thoracic Annals
International Director, Society of Thoracic Surgeons (STS)
Council Member, Asian Society for Cardio-Vascular and Thoracic Surgery (ASCVTS )
Board Member, Asia Thoracoscopic Surgery Education Platform (ATEP)
Council Member, Hong Kong Society of Minimal Access Surgery (HKSMAS)
Specialist Advisor, Hong Kong Society of Medical Oncology
Program Committee, International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS)
Program Committee, Global Health track, International Association for the Study of Lung Cancer (IASLC)

Dr Sihoe received his medical training at the University of Cambridge, and after working in Scotland and England, he returned to practice Cardiothoracic Surgery in Hong Kong and China, with a special interest in minimally invasive Video-Assisted Thoracic Surgery (VATS). He was Clinical Associate Professor of the Department of Surgery at the University of Hong Kong and Chief of Thoracic Surgery at the University of Hong Kong Shenzhen Hospital before recently moving to private practice in Hong Kong. Dr Sihoe is currently Honorary Consultant in Cardiothoracic Surgery at Gleneagles Hong Kong Hospital.

Dr Sihoe is an internationally recognized advocate of ‘next generation’ VATS techniques – especially uniportal and needlescopic chest surgery. He has authored or co-authored over 200 peer-reviewed journal articles, conference abstracts and book chapters in the international literature. He is an avid medical educator, and has been invited to perform surgery and lecture at surgical conferences and educational events on every continent in the world. His work in thoracic surgery and clinical research has won multiple awards – including from the European Society of Thoracic Surgeons (ESTS) and the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS). In 2018, Dr Sihoe was the recipient of the Medical Sciences Technical Award (2nd Class) from the Chinese Medical Association. Dr Sihoe has previously served in leadership roles in multiple Cardio-Thoracic Surgery societies in Europe and Asia, and he continues to actively to promote clinical and academic practices in the specialty through teaching and academic engagements around the world.

Dr Sihoe’s indexed academic and research output can be found at: https://www.ncbi.nlm.nih.gov/pubmed/?term=sihoe+a+%5Bau%5D

Kapat

Bin CAO, MD., Vice President of China-Japan Friendship Hospital, Director of Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital; Vice Director of National Center for Respiratory Medicine; Vice President of Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; Professor of Capital Medical University; Professor of Tsinghua University-Peking University Joint Center for Life Sciences.

He is the President-elect of Chinese Thoracic Society (CTS), Deputy Director of Respiratory & Infectious Disease branch under the Chinese Society of Respiratory Disease, associate editor of Clinical Respiratory Journal, editorial advisory board member of EBoiMedicine, and committee member of Antiviral Group (AVG) of International Society of Influenza and other respiratory virus Diseases (ISIRV).  He has been honored with the title of National Outstanding Individual in the Fight against COVID-19 in 2020, Distinguished Respiratory Academic Contribution Award in 2018, National Award for Science and Technology Progress (Grand Prize) in 2017, Yangtze River Distinguished Professor of Ministry of Education in 2015 and Wu JiePing-Paul Janssen Medical-Pharmaceutical Award in 2014.  

As a senior expert in respiratory infections, his research mainly focuses on the current key issues concerning acute respiratory infections and emerging infectious diseases, including (1) epidemiology, clinical characteristics, and treatment of viral pneumonia, (2) molecular and cellular basis of the pathogenesis of influenza and COVID-19, (3) diagnosis and treatment strategy and drug resistance of infections by drug-resistant pathogens.

Kapat

Abstract: Biology Meets Its Match

In this talk, I describe novel materials, mechanics and device designs for emerging classes of wearable health monitoring systems and implantable, minimally invasive medical devices. These include a variety of electrodes, sensors, and energy harvesting components, with promising applications in bio-integrated electronics, such as self-powered cardiac pacemakers, wearable blood pressure sensors, modulus sensor patches, and brain injectrodes. The devices can be twisted, folded, stretched/flexed and wrapped onto curvilinear surfaces or implanted without damage or significant alteration in operation. The fabrication strategies and design concepts can be applied to various biological substrates and geometries of interest, and thus have the potential to broadly bridge the gap that exists between rigid, boxy electronics and soft, curvy biology.

 

Bio
Canan Dagdeviren is an Assistant Professor at MIT Media Lab, where she leads the Conformable Decoders research group. The group aims to convert the patterns of nature and the human body into beneficial signals and energy.
Dagdeviren earned her Ph.D. in Materials Science and Engineering from the University of Illinois at Urbana-Champaign, where she focused on exploring patterning techniques and creating piezoelectric biomedical systems. Her collective Ph.D. research involved flexible mechanical energy harvesters, multi-functional cardiac vessel stents, wearable blood pressure sensors, and stretchable skin modulus sensing bio-patches.

https://www.media.mit.edu/people/canand/overview/

 

Kapat

Academic Degrees

• Juni 2018                      Adj. Professor in Tobacco prevention, University of Southern Denmark
• February 2018              Professor in Tobacco Prevention, University of Copenhagen
• June 2007                     Master of Public Health, University of Copenhagen
• October 2004                PhD, University of Copenhagen
• January 1988                Medical doctor, University of Copenhagen

https://www.semanticscholar.org/author/C.-Pisinger/5592307 :

Publications 168	H-index 40
Citations 6.164	Highly Influential Citations 239

ORCID ID: https://orcid.org/0000-0002-7970-3168

Employment (recent)
2010-2021            Bispebjerg-Frederiksberg University Hospital, Center for Clinical Research and Disease Prevention, Chief Physician, Senior Researcher

Trusted scientific obligations (selected)

• Head of the Tobacco Control Group (TCC) in the European Respiratory Society, Sept 2017 -Sept 2020
• Member of the Advisory Board in the National Smoking Cessation Database and of “Smokefree Future”, 2018 –
• Member of the Board in the Danish Society of Public Health, 2016 - 2019
• Member of the research assessment committee in the Danish Heart Foundation, 2015-2017
• Vice-president of Danish Society of Epidemiology, 2011-2014
• President of Danish Society of Tobacco Research, 2005-2010

Research related scientific obligations

• Steering member of the scientific committee, European conference on Tobacco or Health, 2020, Berlin

Expert Assignments and international cooperation (selected)

• Co-operation with WHO and the Danish Cancer Society: Implementation of FCTC in Denmark, 2017-18
• Working group on Cancer Plan IV – Prevention, Danish Health Authority, 2016

Organizer/Co-organizer of Scientific Meetings (>10)

Panellist and Workshops (17)

Supervision of PhD Students (7)
Opponent Critic at PhD Defense (8, 4 chairman of assessment committee)

Supervision of Other Students, primarily MPH students, master thesis (15)

Other Scientific Activity: Investigator in 13 randomised trials. Primary investigator in 3 large RCTs. Educated in GCP-guidelines.

Experience as project manager
Investigator and daily manager in one of worlds largest intervention on lifestyle, the Inter99 study (n=13,000), published in BMJ.

Scientific Theses

• PhD Thesis: Smoking cessation and smoking reduction in a general population. The Inter99 study. 5.10.2004
• Master of Public Health (MPH) Thesis: High risk strategy in smoking cessation is feasible on a population-based level. The Inter99 study. 15.06.2007

 

Publications in Books and Booklets (11, 4 peer-reviewed), guest-editor (1)

Commentaries, Other Specialist Publications (19), Reports (16)

Lectures, International, Primary Author/Presenter (41) – invited speaker (22); Lectures, National (99)

Posters, International, Primary Author/Presenter (17); Posters, National, Primary Author (13)

Peer-reviewed publications (138, 40 as first author, 22 as last author)
20 selected shown:

1. Pisinger C, Vestbo J. A new Cochrane review on electronic cigarettes for smoking cessation: should we change our practice? Eur Respir J. 2020 Dec 24;56(6):2004083. doi: 10.1183/13993003.04083-2020. Print 2020 Dec.PMID: 33361450. Impact Factor 12.339.
2. Hjort AV, Christiansen TB, Stage M, Rasmussen KH, Pisinger C, Tjørnhøj-Thomsen T, Klinker CD.
   Programme theory and realist evaluation of the 'Smoke-Free Vocational Schools' research and intervention project: a study protocol. BMJ Open. 2021 Feb 4;11(2). Impact Factor 2.496.
3. Kavousi M, Pisinger C, Barthelemy JC, Smedt D, Koskinas K, Marques-Vidal P, Panagiotakos D, Prescott EB, Tiberi M, Vassiliou VS, Løchen ML. Electronic cigarettes and health with special focus on cardiovascular effects: position paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol. 2020 Jul 29:2047487320941993. doi: 10.1177/2047487320941993. Impact Factor 5.640.

• Vestbo J, Pisinger C. World No Tobacco Day: what's in it for us? Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L1008-L1009. doi: 10.1152/ajplung.00076.2020. Epub 2020 Mar 18. Impact Factor 4.073

5. Vestbo J, Grigg J, Pisinger C, Bush A. World No Tobacco Day: smoking, nicotine and children. Eur Respir J. 2020 May 27;55(5):2001633. doi: 10.1183/13993003.01633-2020. Print 2020 May. Impact Factor 12.339.

• Pisinger C, Vestbo J; ERS Tobacco Control Committee and ERS Senior Leadership. A rational approach to e-cigarettes: challenging ERS policy on tobacco harm reduction. Eur Respir J. 2020 May 7;55(5). Impact Factor 12.339.

• Pisinger C, Dagli E, Filippidis FT, Hedman L, Janson C, Loukides S, Ravara S, Saraiva I, Vestbo J; ERS Tobacco Control Committee, on behalf of the ERS. ERS and Harm Reduction. Eur Respir J. 2019 Dec 4;54(6). Impact Factor 12.339.

8. Kennedy CD, van Schalkwyk MCI, McKee M, Pisinger C. The cardiovascular effects of electronic cigarettes: A systematic review of experimental studies. Prev Med. 2019 Jul 22:105770. doi: 10.1016/j.ypmed.2019.105770. [Epub ahead of print] Review. Impact Factor 3.788.
9. Pisinger C, Mackay J. New Tobacco Products Do Not Protect Public Health. Ann Am Thorac Soc. 2019 Nov;16(11):1363-1365. Impact Factor 4.836.
10. Speyer H, Jakobsen AS, Westergaard C, Nørgaard HCB, Pisinger C, Krogh J, Hjorthøj C, Nordentoft M, Gluud C, Correll CU, Jørgensen KB. Lifestyle Interventions for Weight Management in People with Serious Mental Illness: A Systematic Review with Meta-Analysis, Trial Sequential Analysis, and Meta-Regression Analysis Exploring the Mediators and Moderators of Treatment Effects. Psychother Psychosom. 2019;88(6):350-362. Impact Factor 13.744.
11. Pisinger C, Godtfredsen N, Bender AM. A conflict of interest is strongly associated with tobacco industry-favourable results, indicating no harm of e-cigarettes. Prev Med. 2018 Dec 18. pii: S0091-7435(18)30386-4. doi: 10.1016/j.ypmed.2018.12.011. Impact Factor 3.788.
12. Pisinger C, Green K, Dreiøe B & Larsen C. (2018) A systematic approach to smoking cessation activities in Danish shelters, Journal of Social Distress and the Homeless, 27:2, 118-125, DOI: 10.1080/10530789.2018.1497836. Impact Factor 0.93.
13. Pisinger C, Bjerre Koch MB, Hjortsø E, Jørgensen T, Glümer C. Ups and downs of a peer-based smoking cessation    intervention help tailored to hospital-employees with low socioeconomic status: The RESPEKT Study. Tob. Prev. Cessation 2018;4(June):24. (Impact Factor?)
14. Jakobsen AS, Speyer H, Nørgaard HCB, Karlsen M, Birk M, Hjorthøj C, Mors O, Krogh J, Gluud C, Pisinger C, Nordentoft M. Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial. PLoS One. 2017 Oct 6;12(10). Impact Factor 2.740.
15. Horikoshi, R.N. Beaumont, F. R. Day…C. Pisinger… et al. Genome-wide associations for birth weight and correlations with adult disease. Nature. 2016 Sept. 1. doi:10.1038/nature19806. Impact Factor 42.778.
16. Pisinger C, Døssing M. A systematic review of health effects of electronic cigarettes. Prev Med 2014 Dec;69:248-60 Impact Factor 3.788.
17. Jørgensen T., Jacobsen R.K., Toft U., Aadahl M., Glümer C., Pisinger C. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g3617. Published 9 June 2014 . Impact Factor 30.223.

• Pisinger C, Vestbo J, Borch-Johnsen K, Jorgensen T. Smoking cessation intervention in a large randomised population-based study. The Inter99 study. Prev Med. 2005 Mar;40(3):285-92. Impact Factor 3.788.
• Pisinger C, Vestbo J, Borch-Johnsen K, Jorgensen T. It is possible to help smokers in early motivational stages to quit. The Inter99 study. Prev Med. 2005 Mar;40(3):278-84. Impact Factor 3.788.

Pisinger C, Vestbo J, Borch-Johnsen K, Jorgensen T. Smoking reduction intervention in a large population-based study. The Inter99 study. Prev Med. 2005 Jan;40(1):112-8. Impact Factor 3.788.
Kapat

I am and Immunologist and Associated Professor at the Medical School at Universidad San Pablo-CEU (USP-CEU) since 2014. Additionally, since January 2020 Vice Dean of Research. Currently, I am Principal investigator (PI) in two competitive national projects funded by Instituto de Salud Carlos III (ISCIII, Spain) focus in the use of omic strategies for the identification of novel biomarkers in severe allergic asthma and active member of the coordination group of the Program 3 “Severe allergic phenotypes and novel interventions strategies” of the  Spanish National Network for Allergy Research (ARADYAL).
I am actively involved in national and international Societies of Allergy and Clinical Immunology: Sociedad Española de Alergología e Inmunología Clínica (SEAIC), and European Academy of Allergy and Clinical Immunology (EAACI), as demonstrated by my nomination as Chair of the Working Group on Genomics and Proteomics at the EAACI.
I defend my Thesis in 2006 in the Hospital Universitario Ramon y Cajal and afterwards, in 2010, I move for a 4-years postdoc at Mount Sinai School of Medicine, in New York City. In 2010 I obtain a competitive grant to reincorporate in the Spanish Scientific System at the Center of Biological Research (CIB-CSIC).

Kapat

Prof. Alvar Agustí, MD, PhD, FRCP, FERS

Alvar Agustí is Professor of Medicine at the University of Barcelona and senior consultant at Hospital Clinic, also in Barcelona (Spain). His main research interest relates to clinical and translational research in chronic airway diseases. He has published more than 500 papers in peer-reviewed journals (H-Index 105) and has over 40 contributions to books. Over the past few years, he has led several important conceptual changes in the field of COPD, including that of treatable traits and the trajectome. He is regularly invited to speak at international conferences and symposia. He is a member of several professional societies, including the American Thoracic Society (where he has been associated editor of the Am. J. Respir. And Crit. Care Med.), and the European Respiratory Society (in which he has been a Member of its Executive Committee). He has a sit at the Royal Academy of Medicine of the Balearic Islands and also of Catalunya, he is an Honorary Fellow of the Royal College of Physicians of Edinburgh (FRCP), a Fellow of the European Respiratory Society (FERS), Honorary member of ERS, and current Chair of the Board of Directors of GOLD (www.goldcopd.org).

Kapat

Dr. Pandula Siribaddana is a Senior Lecturer in Medical Informatics/medical education at the Postgraduate Institute of Medicine (PGIM) of the University of Colombo with research interests in digital health, education technologies, ICT4D, public health informatics, and blended learning. He is a medical doctor by profession and obtained his doctoral degree from the University of Oslo, Norway. Dr Siribaddana has contributed to the development of health informatics as a speciality in medicine in Sri Lanka as part of the Speciality Board in Biomedical informatics at the PGIM creating a more than 200 strong cohort of medically qualified health informaticians in the country. He has a passion towards utilizing digital technologies towards empowering people and this has led to the creation of the Self Shield System, the flagship COVID-19 response system by the Commonwealth Centre for Digital Health (CWCDH). At present, Dr. Siribaddana is the Hon. Treasurer of the Health Informatics Society of Sri Lanka (HISSL) and the innovations lead at the CWCDH. 

Kapat

PERSONAL DETAILS Name: Sinem Family Name: Taṣ Work Address: Lund University, Faculty of Medicine, Department of Experimental Medical Sciences, 221 84 Lund, Sweden Email: [email protected]

CURRENT POSITION 2021- Associate Researcher (100% research position), Lung Bioengineering and Regeneration, Faculty of Medicine, Lund University June, 2018-2020 Marie Curie Cofund/European Respiratory Society (ERS) RESPIRE3 Fellow Lung Bioengineering and Regeneration, Faculty of Medicine, Lund University

RELEVANT PREVIOUS POSITIONS Mar-June 2018 Postdoctoral fellow Lung Bioengineering and Regeneration, Faculty of Medicine, Lund University 2017-2018 Postdoctoral fellow, Material Science and Technology of Polymers, University of Twente, the Netherlands 2016-2017 Industral Researcher Parthian Technologies B.V., Hengelo, the Netherlands

EDUCATION 2011- 2015 PhD. Membrane Science and Engineering, University of Twente (Enschede, the Netherlands), Membrane Science and Technology Promotor: Prof. Dr. Ir. Kitty Nijmeijer Defense date: 11-03-2016 2008-2011 MSc. Material Science and Engineering Sabanci University (Istanbul, Turkey) Supervisor: Prof. Dr. Yuda Yurum 2004-2008 BSc in Chemical Engineering Hacettepe University (Ankara, Turkey)

INDEPENDENT RESEARCH FUNDING 2020-2022 Vinnova, High-throughput screening with primary human airway cells for repurposing drugs to prevent COVID-19, (co-applicant, PM) 2020-2021 Fysiografiska Research Grant Medicine, Designer coating for ECMO endothelialization, (main applicant, PI) 2018-2020 Marie Curie Cofund/ European Respiratory Society (ERS) RESPIRE3 Fellowship, 3D bioprinting for lung tissue engineering, (main applicant, PI) 2019-2020 Fysiografiska Research Grant Medicine, Clickable enzyme cleavable hydrogels for pulmonary tissue engineering, (main applicant, PI) 2019-2020 Stiftelsen Lars Hiertas Minne, Use of decellularized porcine lung derived extracellular matrix hydrogel for lung organoid culture,(main applicant, PI)

AWARDS 2020 Bursary for 19th ERS Virtual Lung Science Conference 2018 European Commission Seal of Excellence Award for Marie Curie Individual Fellowship Proposal 2016 R&D cooperation subsidy project grant Dutch Ministry of Economic Affairs, Role:PI 2014 Best poster award (Innovation) Poster Day of the Dutch Membrane Society (NMG)

ORGANIZATIONAL ACTIVITIES 2019- Organizer of Matrix Biology Seminars, Lund University, Department of Experimental Medical Science (EMV)

MEMBERSHIP European Respiratory Society (ERS), European Membrane Society, European Biomaterials Society

Kapat

Professor Bartolome Celli graduated from Universidad Central de Venezuela, completed his training in Internal Medicine, and was Chief Medical Resident, at the Boston City Hospital. He then trained in Pulmonary and Critical Care Medicine at the Boston University School of Medicine. Currently, he is Professor of Medicine at Tufts and Harvard Medical School. Dr. Celli has published over 400 peer reviewed scientific papers, 425 abstracts and edited several books. He has been the Chairman of the Committee that established the American Thoracic Society and European Respiratory Society guidelines for the diagnosis and treatment of COPD. In addition, he is in the Scientific Committee of the Global Obstructive Lung Disease initiative and currently serves in the Board of Directors of GOLD. He has also been Chairman of the Clinical Assembly of the ATS and President of the Massachusetts Thoracic Society and New England College of Chest Physicians. Although caring for patients provides unique pleasure, his greatest achievement is to have personally helped mentor many young careers in Medicine. Ten Professors of Medicine, one Dean and two Vice-Deans of medical schools in the United States and in Colombia are among the 65 individuals in whom he has tried to instill a love for the profession, a desire to generate new knowledge, and respect for our fellow humans and for the world at large. His trainees are located in the United States, Europe, the Middle East, Japan and Latin America.

Kapat

Dr Soumya Swaminathan was appointed WHO’s first Chief Scientist in March 2019. A paediatrician from India and a globally recognized researcher on tuberculosis and HIV, she brings with her 30 years of experience in clinical care and research and has worked throughout her career to translate research into impactful programmes. Dr Swaminathan was Secretary to the Government of India for Health Research and Director General of the Indian Council of Medical Research from 2015 to 2017. In that position, she focused on bringing science and evidence into health policy making, building research capacity in Indian medical schools and forging south-south partnerships in health sciences. From 2009 to 2011, she also served as Coordinator of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases in Geneva.
She received her academic training in India, the United Kingdom, and the United States of America, and has published more than 350 peer-reviewed publications and book chapters. She is an elected Foreign Fellow of the US National Academy of Medicine and a Fellow of all three science academies in India. The Science division’s role is to ensure that WHO stays ahead of the curve and leverages advances in science and technology for public health and clinical care, as well as ensuring that the norms, standards and guidelines produced by WHO are scientifically excellent, relevant and timely. Her vision is to ensure that WHO is at the cutting edge of science and is able to translate new knowledge into meaningful impact on population health worldwide.

Kapat

Professional Experience

2021 -  to date Director, Institute of Lung Biology and Disease (ILBD) and Comprehensive Pneumology Center (CPC), Helmholtz Zentrum München
2017 – 2020    Leadership-Team, Institute ILBD and CPC, Helmholtz Zentrum München
2012 – to date PI and member, German Center for Lung Research (DZL) in Disease Area COPD, DPLD, ELD and Platform Imaging
2010 – 2012    Deputy Director, Institute ILBD and CPC, Helmholtz Zentrum München
2009 – to date  Group Leader “Immunopathology of COPD”, Institute ILBD and CPC, Helmholtz Zentrum München
2008 – 2009    Postdoctoral fellow, Department of Clinical Chemistry & Molecular Diagnostics, Univ. Hospital Giessen & Marburg GmbH, Marburg
2004 – 2008     Postdoctoral fellow, Department of Internal Medicine clinical research group “chronic airway diseases” Philipps-University of Marburg
2002 – 2004     Participant of the Graduate Program of the "Sonderforschungsbereich 534 Grundlagen der vaskulären Medizin" University Hospital Giessen

1999 - 2002     Doc. Vet. Med. Veterinary Medicine, Justus Liebig University, Giessen “Phäno- und Genotypisierung von Streptokokken der serologischen Gruppe B (Streptococcus agalactiae), isoliert von verschiedenen Tierarten“

2019 – to date PI and Visiting Scientist at the University of Koc, Istanbul, Turkey
2019 – to date  Editorial Board member of Frontier Immunology
2019 – 2022    Member of ATS, Assembly on Respiratory Cell and Molecular Biology (RCMB) organization committee
2018 – to date  Editorial Board member of Allergy
2013 – to date  Editorial Board member of PlosOne
2013 – 2017    Member of ATS, Assembly on Respiratory Cell and Molecular Biology (RCMB) organization committee
2013 – to date  Faculty member of Munich International Autumn School (MIAS)
2012– to date Member of Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health (HICE)
2010 – to date Head of Small Animal Platform, (SMAP) at CPC
2009 – to date  Member of American Thoracic Society (ATS)
2008 – to date Member of European Respiratory Society (ERS)
2005 – to date  Junior-Member of European Academy of Allergy and Clinical Immunology (EAACI)

Nature Communication, American Journal of Respiratory and Critical Care Medicine, American Journal of Respiratory Cell and Molecular Biology, Science Translational Medicine, PloS One, European Respiratory Journal, Disease Models & Mechanisms, International Archives of Allergy and Immunology, Respiratory Research, Toxicological Sciences, European Journal of Pharmaceutics and Biopharmaceutics, FASEB, Journal of Innate Immunity.

2021

Inhibition of LTβR-signalling activates Wnt-induced regeneration in lung. Conlon TM, John-Schuster G, Heide D, Pfister D, Lehmann M, Hu Y, Ertüz Z, Lopez MA, Ansari M, Strunz M, Mayr C, Angelidis I, Ciminieri C, Costa R, Kohlhepp MS, Guillot A, Günes G, Jeridi A, Funk MC, Beroshvili G, Prokosch S, Hetzer J, Verleden SE, Alsafadi H, Lindner M, Burgstaller G, Becker L, Irmler M, Dudek M, Janzen J, Goffin E, Gosens R, Knolle P, Pirotte B, Stoeger T, Beckers J, Wagner D, Singh I, Theis FJ, de Angelis MH, O'Connor T, Tacke F, Boutros M, Dejardin E, Eickelberg O, Schiller HB, Königshoff M, Heikenwalder M, Yildirim AÖ. Nature. 2020 Dec;588(7836):151-156. doi: 10.1038/s41586-020-2882-8. Epub 2020 Nov 4.PMID: 33149305 

1. TRPV4 channels are essential for alveolar epithelial barrier function as protection from lung edema. Weber J, Rajan S, Schremmer C, Chao YK, Krasteva-Christ G, Kannler M, Yildirim AÖ, Brosien M, Schredelseker J, Weissmann N, Grimm C, Gudermann T, Dietrich A. JCI Insight. 2020 Oct 15;5(20):e134464. doi: 10.1172/jci.insight.134464.PMID: 32931478 
2. A proof-of principal study using phase-contrast imaging for the detection of large airway pathologies after lung transplantation. Umkehrer S, Morrone C, Dinkel J, Aigner L, Reiser MF, Herzen J, Yildirim AÖ, Pfeiffer F, Hellbach K. Sci Rep. 2020 Oct 28;10(1):18444. doi: 10.1038/s41598-020-75185-4.
3. Cathepsin B promotes collagen biosynthesis, which drives bronchiolitis obliterans syndrome. Morrone C, Smirnova NF, Jeridi A, Kneidinger N, Hollauer C, Schupp JC, Kaminski N, Jenne D, Eickelberg O, Yildirim AÖ.  Eur Respir J. 2021 May 13;57(5):2001416. doi: 10.1183/13993003.01416-2020. Print 2021 May. Acta Orthop Traumatol Turc. 2020 Nov;54(6):634-638. doi: 10.5152/j.aott.2020.20232.

Effects of morphological changes in the patellar tendon on the development of anterior knee pain after intramedullary nailing for tibial shaft fractures: A retrospective comparative study. Acta Orthop Traumatol Turc. 2020 Nov;54(6):634-638. doi: 10.5152/j.aott.2020.20232.

1. Publisher Correction: Inhibition of LTβR signalling activates WNT-induced regeneration in lung. Conlon TM, John-Schuster G, Heide D, Pfister D, Lehmann M, Hu Y, Ertüz Z, Lopez MA, Ansari M, Strunz M, Mayr C, Angelidis I, Ciminieri C, Costa R, Kohlhepp MS, Guillot A, Günes G, Jeridi A, Funk MC, Beroshvili G, Prokosch S, Hetzer J, Verleden SE, Alsafadi H, Lindner M, Burgstaller G, Becker L, Irmler M, Dudek M, Janzen J, Goffin E, Gosens R, Knolle P, Pirotte B, Stoeger T, Beckers J, Wagner D, Singh I, Theis FJ, de Angelis MH, O'Connor T, Tacke F, Boutros M, Dejardin E, Eickelberg O, Schiller HB, Königshoff M, Heikenwalder M, Yildirim AÖ. Nature. 2021 Jan;589(7842):E6. doi: 10.1038/s41586-020-03087-6.PMID: 33353984 
2. Local tissue development of type 1 innate lymphoid cells: guided by interferon-gamma. Conlon TM, Knolle PA, Yildirim AÖ. Signal Transduct Target Ther. 2021 Jul 29;6(1):287. doi: 10.1038/s41392-021-00705-1.PMID: 34326313.
3. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Muus C, Luecken MD, Eraslan G, Sikkema L, Waghray A, Heimberg G, Kobayashi Y, Vaishnav ED, Subramanian A, Smillie C, Jagadeesh KA, Duong ET, Fiskin E, Triglia ET, Ansari M, Cai P, Lin B, Buchanan J, Chen S, Shu J, Haber AL, Chung H, Montoro DT, Adams T, Aliee H, Allon SJ, Andrusivova Z, Angelidis I, Ashenberg O, Bassler K, Bécavin C, Benhar I, Bergenstråhle J, Bergenstråhle L, Bolt L, Braun E, Bui LT, Callori S, Chaffin M, Chichelnitskiy E, Chiou J, Conlon TM, Cuoco MS, Cuomo ASE, Deprez M, Duclos G, Fine D, Fischer DS, Ghazanfar S, Gillich A, Giotti B, Gould J, Guo M, Gutierrez AJ, Habermann AC, Harvey T, He P, Hou X, Hu L, Hu Y, Jaiswal A, Ji L, Jiang P, Kapellos TS, Kuo CS, Larsson L, Leney-Greene MA, Lim K, Litviňuková M, Ludwig LS, Lukassen S, Luo W, Maatz H, Madissoon E, Mamanova L, Manakongtreecheep K, Leroy S, Mayr CH, Mbano IM, McAdams AM, Nabhan AN, Nyquist SK, Penland L, Poirion OB, Poli S, Qi C, Queen R, Reichart D, Rosas I, Schupp JC, Shea CV, Shi X, Sinha R, Sit RV, Slowikowski K, Slyper M, Smith NP, Sountoulidis A, Strunz M, Sullivan TB, Sun D, Talavera-López C, Tan P, Tantivit J, Travaglini KJ, Tucker NR, Vernon KA, Wadsworth MH, Waldman J, Wang X, Xu K, Yan W, Zhao W, Ziegler CGK; NHLBI LungMap Consortium; Human Cell Atlas Lung Biological Network. Nat Med. 2021 Mar;27(3):546-559. doi: 10.1038/s41591-020-01227-z. Epub 2021 Mar 2.
4. A drug screen with approved compounds identifies amlexanox as a novel Wnt/β-catenin activator inducing lung epithelial organoid formation. Costa R, Wagner DE, Doryab A, De Santis MM, Schorpp K, Rothenaigner I, Lehmann M, Baarsma HA, Liu X, Schmid O, Campillos M, Yildirim AÖ, Hadian K, Königshoff M. Br J Pharmacol. 2021 Jun 5. doi: 10.1111/bph.15581. PMID: 34089180

2020

Conlon TM, John-Schuster G, Heide D, Pfister D, Lehmann M, Hu Y, Ertüz Z, Lopez MA, Ansari M, Strunz M, Mayr C, Ciminieri C, Costa R, Kohlhepp MS, Guillot A, Günes G, Jeridi A, Funk MC, Beroshvili G, Prokosch S, Hetzer J, Verleden SE, Alsafadi H, Lindner M, Burgstaller G, Becker L, Irmler M, Dudek M, Janzen J, Goffin E, Gosens R, Knolle P, Pirotte B, Stoeger T, Beckers J, Wagner D, Singh I, Theis FJ, de Angelis MH, O'Connor T, Tacke F, Boutros M, Dejardin E, Eickelberg O, Schiller HB, Königshoff M, Heikenwalder M, Yildirim AÖ. Inhibition of LTβR-signalling blocks epithelial apoptosis and activates Wnt-induced regeneration in lung. Nature 2020. August doi.org/10.1038/s41586-020-2882-8

Kapat

CURRICULUM VITAE

PETER JAKSCH, MD

 

Personal Information:

 

Name:                                                 Peter Jaksch

Place of birth :                                  Vienna

Citzenship :                                       Austria

Martial status :                                 Ingrid Jaksch

Children :                                         Adrian 1988
Celina 1991

Languages:                                       German, English
Education:

High school:                                      1972-1980  
final graduate May 1980

 

Medical school:                                 Vienna Medical School
Medical Degree at University of Vienna December 1988

Postgraduate training:

1. Internship Hospital Lainz, Vienna

1. Residency in Pulmonology,  Hospital Lainz

 

since 2000      Consultant Pulmonologist
Dept of Cardio-Thoracic Surgery
General Hospital Vienna

2015                habilitation                            


Membership in Professional Societies:

                                    European Respiratory Society (ERS)

International  Society for Heart and Lung Transplantation (ISHLT)

                                    Österreichische Gesellschaft für Pulmologie (ÖGP)

                                    Austrian Transplant Society

Kapat